EHR Nudges to Improve Quality of Care in HF
Launched by NORTHWESTERN UNIVERSITY · Oct 23, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new tool designed for pharmacists to help improve care for patients with heart failure, specifically those with reduced ejection fraction. The goal is to see if this tool can help pharmacists follow treatment guidelines more closely, which could lead to better health outcomes for patients. The study will evaluate how well this tool works and how easily it can be used in practice.
To participate in this trial, you need to be a pharmacist working at Northwestern Medicine's Medication Adjusted to Target (MAT) Clinic. There are no specific exclusions, so if you meet this requirement, you can join. As a participant, you’ll be involved in testing this decision support tool to see if it helps improve the quality of care for patients with heart failure. Your contribution could play a vital role in enhancing treatment for individuals dealing with this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Pharmacist at Northwestern Medicine participating in the Medication Adjusted to Target (MAT) Clinic
- Exclusion Criteria:
- • None
About Northwestern University
Northwestern University is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a robust infrastructure that supports interdisciplinary collaboration, Northwestern leverages its expertise in various fields, including medicine, engineering, and social sciences, to drive groundbreaking studies. The university is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring that all clinical trials are conducted with the utmost integrity and focus on participant safety. Through its Clinical Trials Office, Northwestern aims to translate scientific discoveries into effective therapies, ultimately enhancing health outcomes and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported